

The Recombinant Human CCL22 by Applied Biological Materials (ABM) is a tag-free, E. coli-expressed CC chemokine (MDC) at >95% purity, for CCR4-mediated Treg and Th2 cell recruitment and tumor immune evasion research. Available in 20 µg (Z101015) and 1.0 mg (Z101019).

